Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Klein

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Optics Letters|October 28, 2009
Depth-resolved holographic imaging through scattering media by photorefractionS C Hyde, N P Barry, R Jones, et al.
Optics Letters|December 12, 2007
Enhanced responsivity of non-steady-state photoinduced electromotive force sensors using asymmetric interdigitated contactsD D Nolte, J A Coy, G J Dunning, et al.
HIV Medicine|July 4, 2015
Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in CanadaL Brunet, E E M Moodie, J Cox, et al.
HIV Medicine|May 20, 2014
HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patientsC Cooper, K C Rollet-Kurhajec, J Young, et al.
The International Journal on Drug Policy|September 17, 2019
"Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian citiesM E Pearce, K Jongbloed, L Demerais, et al.
HIV Medicine|December 6, 2013
Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapyP Ndumbi, J Gillis, J Raboud, et al.
Current Oncology (Toronto, Ont.)|March 29, 2020
Acceptability of anal cancer screening tests for women living with HIV in the EVVA studyE Kaufman, C de Castro, T Williamson, et al.
HIV Medicine|September 2, 2014
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in CanadaH Samji, T E Taha, D Moore, et al.
HIV Clinical Trials|April 19, 2012
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapyJ Raboud, A Anema, D Su, et al.
HIV Medicine|July 8, 2016
Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapyS Kesselring, A Cescon, G Colley, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Optics Letters|October 28, 2009
Depth-resolved holographic imaging through scattering media by photorefractionS C Hyde, N P Barry, R Jones, et al.
Optics Letters|December 12, 2007
Enhanced responsivity of non-steady-state photoinduced electromotive force sensors using asymmetric interdigitated contactsD D Nolte, J A Coy, G J Dunning, et al.
HIV Medicine|July 4, 2015
Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in CanadaL Brunet, E E M Moodie, J Cox, et al.
HIV Medicine|May 20, 2014
HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patientsC Cooper, K C Rollet-Kurhajec, J Young, et al.
The International Journal on Drug Policy|September 17, 2019
"Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian citiesM E Pearce, K Jongbloed, L Demerais, et al.
HIV Medicine|December 6, 2013
Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapyP Ndumbi, J Gillis, J Raboud, et al.
Current Oncology (Toronto, Ont.)|March 29, 2020
Acceptability of anal cancer screening tests for women living with HIV in the EVVA studyE Kaufman, C de Castro, T Williamson, et al.
HIV Medicine|September 2, 2014
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in CanadaH Samji, T E Taha, D Moore, et al.
HIV Clinical Trials|April 19, 2012
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapyJ Raboud, A Anema, D Su, et al.
HIV Medicine|July 8, 2016
Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapyS Kesselring, A Cescon, G Colley, et al.
Pageof 6